139 related articles for article (PubMed ID: 2479717)
1. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
[TBL] [Abstract][Full Text] [Related]
3. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
Zhao B; Sample CE
J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
[TBL] [Abstract][Full Text] [Related]
4. A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA.
Majerciak V; Yang W; Zheng J; Zhu J; Zheng ZM
J Virol; 2019 Jan; 93(2):. PubMed ID: 30355690
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
J Virol; 2018 May; 92(9):. PubMed ID: 29467311
[TBL] [Abstract][Full Text] [Related]
6. LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells.
Zhang J; Sommermann T; Li X; Gieselmann L; de la Rosa K; Stecklum M; Klein F; Kocks C; Rajewsky K
Front Immunol; 2023; 14():1331730. PubMed ID: 38169736
[TBL] [Abstract][Full Text] [Related]
7. The replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.
Koons MD; Van Scoy S; Hearing J
J Virol; 2001 Nov; 75(22):10582-92. PubMed ID: 11602700
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations.
Lei H; Li T; Li B; Tsai S; Biggar RJ; Nkrumah F; Neequaye J; Gutierrez M; Epelman S; Mbulaiteye SM; Bhatia K; Lo SC
Sci Rep; 2015 Nov; 5():16706. PubMed ID: 26593963
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) nuclear antigen 1 colocalizes with cellular replication foci in the absence of EBV plasmids.
Ito S; Yanagi K
J Virol; 2003 Mar; 77(6):3824-31. PubMed ID: 12610157
[TBL] [Abstract][Full Text] [Related]
10. Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.
Spender LC; Cornish GH; Rowland B; Kempkes B; Farrell PJ
J Virol; 2001 Apr; 75(8):3537-46. PubMed ID: 11264343
[TBL] [Abstract][Full Text] [Related]
11. Rep*: a viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus.
Kirchmaier AL; Sugden B
J Virol; 1998 Jun; 72(6):4657-66. PubMed ID: 9573229
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase.
Kashuba E; Kashuba V; Sandalova T; Klein G; Szekely L
BMC Cell Biol; 2002 Aug; 3():23. PubMed ID: 12199906
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes.
Yenamandra SP; Hellman U; Kempkes B; Darekar SD; Petermann S; Sculley T; Klein G; Kashuba E
Cell Mol Life Sci; 2010 Dec; 67(24):4249-56. PubMed ID: 20593215
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma.
Sheen TS; Huang YT; Chang YL; Ko JY; Wu CS; Yu YC; Tsai CH; Hsu MM
Jpn J Cancer Res; 1999 Dec; 90(12):1285-92. PubMed ID: 10665644
[TBL] [Abstract][Full Text] [Related]
15. Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes.
Sompallae R; Callegari S; Kamranvar SA; Masucci MG
PLoS One; 2010 Aug; 5(8):e12052. PubMed ID: 20706582
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive epitope mapping of the Epstein-Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals.
Provenzano M; Selleri S; Jin P; Wang E; Werden R; Slezak S; Adams SD; Panelli MC; Leitman SF; Stroncek DF; Marincola FM
Cancer Immunol Immunother; 2007 Jul; 56(7):1047-63. PubMed ID: 17124584
[TBL] [Abstract][Full Text] [Related]
17. Cloning and analysis of the Epstein-Barr virus glycoprotein 350 genes.
Chang SH; Kim SH; Lee WK; Kim HJ; Choi SH; Park JH; Jang HS; Chung GH; Kwon TH; Kim DH; Yang MS; Jang YS
Mol Cells; 1998 Oct; 8(5):585-93. PubMed ID: 9856346
[TBL] [Abstract][Full Text] [Related]
18. Transcribed B lymphocyte genes and multiple sclerosis risk genes are underrepresented in Epstein-Barr Virus hypomethylated regions.
Ong LTC; Parnell GP; Afrasiabi A; Stewart GJ; Swaminathan S; Booth DR
Genes Immun; 2020 Feb; 21(2):91-99. PubMed ID: 31619767
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a novel Epstein-Barr Virus-encoded circular RNA from LMP-2 Gene.
Tan KE; Ng WL; Marinov GK; Yu KH; Tan LP; Liau ES; Goh SY; Yeo KS; Yip KY; Lo KW; Khoo AS; Yap LF; Ea CK; Lim YY
Sci Rep; 2021 Jul; 11(1):14392. PubMed ID: 34257379
[TBL] [Abstract][Full Text] [Related]
20. Germinal Center Cytokines Driven Epigenetic Control of Epstein-Barr Virus Latency Gene Expression.
Yifei L; Jinjie Y; Beri NR; Roth LG; Ethel C; Benjamin E G
bioRxiv; 2024 Jan; ():. PubMed ID: 38260430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
